KR20130140069A - 피부의 스트레스 축적도의 평가방법 - Google Patents
피부의 스트레스 축적도의 평가방법 Download PDFInfo
- Publication number
- KR20130140069A KR20130140069A KR1020137014928A KR20137014928A KR20130140069A KR 20130140069 A KR20130140069 A KR 20130140069A KR 1020137014928 A KR1020137014928 A KR 1020137014928A KR 20137014928 A KR20137014928 A KR 20137014928A KR 20130140069 A KR20130140069 A KR 20130140069A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- hsp27
- stratum corneum
- expression level
- stress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 238000009825 accumulation Methods 0.000 title claims abstract description 40
- 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 claims abstract description 133
- 210000003491 skin Anatomy 0.000 claims abstract description 117
- 210000000434 stratum corneum Anatomy 0.000 claims abstract description 108
- 230000014509 gene expression Effects 0.000 claims abstract description 84
- 230000037307 sensitive skin Effects 0.000 claims abstract description 31
- 238000011156 evaluation Methods 0.000 claims abstract description 28
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims abstract 17
- 238000005259 measurement Methods 0.000 claims description 24
- 230000037311 normal skin Effects 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 10
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 6
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 6
- 230000000052 comparative effect Effects 0.000 claims description 5
- 102000005623 HSP27 Heat-Shock Proteins Human genes 0.000 description 116
- 230000035882 stress Effects 0.000 description 57
- 108090000623 proteins and genes Proteins 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 42
- 238000002474 experimental method Methods 0.000 description 22
- 239000002537 cosmetic Substances 0.000 description 17
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 15
- 238000011002 quantification Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 9
- 206010012438 Dermatitis atopic Diseases 0.000 description 8
- 201000008937 atopic dermatitis Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 210000000245 forearm Anatomy 0.000 description 6
- 238000000265 homogenisation Methods 0.000 description 6
- 238000000751 protein extraction Methods 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 238000002731 protein assay Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011544 gradient gel Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- BBKDWPHJZANJGB-IKJXHCRLSA-N quizalofop-P-tefuryl Chemical compound O=C([C@H](OC=1C=CC(OC=2N=C3C=CC(Cl)=CC3=NC=2)=CC=1)C)OCC1CCCO1 BBKDWPHJZANJGB-IKJXHCRLSA-N 0.000 description 3
- 238000007788 roughening Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101001036709 Homo sapiens Heat shock protein beta-1 Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940021231 clearskin Drugs 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 102000053548 human HSPB1 Human genes 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000000035 BCA protein assay Methods 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101150096895 HSPB1 gene Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 230000008799 immune stress Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2011-040355 | 2011-02-25 | ||
| JP2011040355 | 2011-02-25 | ||
| JPJP-P-2012-012033 | 2012-01-24 | ||
| JP2012012033A JP5658696B2 (ja) | 2011-02-25 | 2012-01-24 | 皮膚のストレス蓄積度の評価方法 |
| PCT/JP2012/053345 WO2012114932A1 (ja) | 2011-02-25 | 2012-02-14 | 皮膚のストレス蓄積度の評価方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20130140069A true KR20130140069A (ko) | 2013-12-23 |
Family
ID=46720714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020137014928A Withdrawn KR20130140069A (ko) | 2011-02-25 | 2012-02-14 | 피부의 스트레스 축적도의 평가방법 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5658696B2 (enExample) |
| KR (1) | KR20130140069A (enExample) |
| CN (1) | CN103380375A (enExample) |
| TW (1) | TWI580964B (enExample) |
| WO (1) | WO2012114932A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103808940B (zh) * | 2012-11-02 | 2017-06-06 | 株式会社芳珂 | 粗糙肌肤的评价方法 |
| JP5731598B2 (ja) * | 2012-11-02 | 2015-06-10 | 株式会社ファンケル | 荒れ肌の評価方法 |
| JP5775540B2 (ja) * | 2013-02-22 | 2015-09-09 | 株式会社ファンケル | 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法 |
| JP2015072226A (ja) * | 2013-10-03 | 2015-04-16 | 住友ベークライト株式会社 | 検査方法 |
| JP5977268B2 (ja) * | 2014-01-09 | 2016-08-24 | 株式会社ファンケル | 肌理の評価方法 |
| JP6530646B2 (ja) * | 2015-06-22 | 2019-06-12 | 株式会社ファンケル | 頭皮の圧縮応力の評価方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1703229B (zh) * | 2002-10-02 | 2011-01-05 | 英属哥伦比亚大学 | 治疗前列腺和其他癌的组合物和其制备药物的用途 |
| JP4469762B2 (ja) * | 2005-07-26 | 2010-05-26 | 株式会社資生堂 | 敏感肌の評価方法及びその評価キット |
| CN101248192B (zh) * | 2005-08-23 | 2013-02-20 | 株式会社芳珂 | 皮肤老化标记物及其利用技术 |
| JP4954908B2 (ja) * | 2008-01-21 | 2012-06-20 | 株式会社 資生堂 | 角層タンパク質の可溶性タンパク質の量比を指標とした肌質の評価方法 |
-
2012
- 2012-01-24 JP JP2012012033A patent/JP5658696B2/ja active Active
- 2012-02-14 WO PCT/JP2012/053345 patent/WO2012114932A1/ja not_active Ceased
- 2012-02-14 CN CN2012800090971A patent/CN103380375A/zh active Pending
- 2012-02-14 KR KR1020137014928A patent/KR20130140069A/ko not_active Withdrawn
- 2012-02-21 TW TW101105615A patent/TWI580964B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI580964B (zh) | 2017-05-01 |
| JP2012189581A (ja) | 2012-10-04 |
| JP5658696B2 (ja) | 2015-01-28 |
| TW201235662A (en) | 2012-09-01 |
| WO2012114932A1 (ja) | 2012-08-30 |
| CN103380375A (zh) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6022260B2 (ja) | 皮膚状態の評価方法 | |
| KR20130140069A (ko) | 피부의 스트레스 축적도의 평가방법 | |
| Huygen et al. | Skin barrier function assessment: electrical impedance spectroscopy is less influenced by daily routine activities than transepidermal water loss | |
| JP5065237B2 (ja) | アトピー性皮膚炎の局所病態の非侵襲的評価方法 | |
| Zeytun | Demodex (Acari: Demodicidae) infestation in the elderly and its relationship with the skin parameters such as moisture, pH, and temperature: a cross-sectional study. | |
| TWI600904B (zh) | 皮膚應激蓄積度的評價方法 | |
| CN104007056B (zh) | 对紫外线损伤的抵抗性的评价方法 | |
| Barbosa et al. | Body mass index as discriminator of the lean mass deficit and excess body fat in institutionalized elderly people | |
| TWI541506B (zh) | 皮膚壓力蓄積的評價方法 | |
| TWI595235B (zh) | 粗糙肌膚的評估方法 | |
| Kazemi et al. | Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study | |
| JP4469762B2 (ja) | 敏感肌の評価方法及びその評価キット | |
| JP4473926B1 (ja) | 紫外線による皮膚黒化傾向の評価方法 | |
| JP2021117164A (ja) | 皮膚炎症状態の評価方法 | |
| HK1187677A (en) | Method of evaluating degree of skin stress accumulation | |
| Murdan et al. | The pH of the human nail plate | |
| HK1186245A (en) | Analysis method for skin stress accumulation | |
| Robinson | 45 Noninvasive Clinical Assessment of Skin Irritation/Inflammation | |
| KR20130098211A (ko) | 피부의 스트레스 축적량의 측정방법 | |
| Norton | Age-Related Changes in Human Skin | |
| JP2024033289A (ja) | 皮膚弾力性のマーカー及びその利用 | |
| Sanad et al. | Evaluation of Serum Level and Tissue Expression of Galectin-7 in Patients with Hypertrophic Scars | |
| EP4469600A1 (en) | Biomarkers predictive of atopic dermatitis | |
| Rojvutthikun et al. | PREVALENCE AND ASSOCIATION FACTORS OF XEROSIS IN MIDDLE-AGED AND ELDERLY IN THAI PEOPLE: A CROSS-SECTIONAL STUDY | |
| Farage et al. | Sensitive skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20130611 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |